Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Current Signal: BUY (auto-tracking)
3.25% $9.53
America/New_York / 18 mar 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 737.69 mill |
EPS: | -1.620 |
P/E: | -5.88 |
Earnings Date: | Apr 25, 2024 |
SharesOutstanding: | 77.41 mill |
Avg Daily Volume: | 0.778 mill |
RATING 2024-03-18 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Sell | |
Return On Asset: | Neutral | |
DE: | Strong Buy | |
P/E: | Strong Sell | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -5.88 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -5.88 | industry: PE -4.88 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 8.76 - 10.30 ( +/- 8.12%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-11 | Barnes Stephen H. | Buy | 770 | Common Stock |
2024-03-12 | Barnes Stephen H. | Sell | 222 | Common Stock |
2024-03-11 | Barnes Stephen H. | Sell | 770 | Restricted Stock Units |
2024-03-11 | Cavanaugh Robert N | Buy | 710 | Common Stock |
2024-03-12 | Cavanaugh Robert N | Sell | 252 | Common Stock |
INSIDER POWER |
---|
-24.62 |
Last 100 transactions |
Buy: 170 170 | Sell: 284 053 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $9.53 (3.25% ) |
Volume | 0.326 mill |
Avg. Vol. | 0.778 mill |
% of Avg. Vol | 41.91 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $13.32 | N/A | Active |
---|
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.